Sarkar et al. found antidepressant treatment before IFN-α treatment lowered mean depression scores and had a lower incidence of MDD (Sarkar and Schaefer, 2014; Köhler et al., 2016). This evidence concerns the gene IFNA1 and depressive symptom measurement.